0
Original Contribution |

Correlation of Specific Amyloid-β Oligomers With Tau in Cerebrospinal Fluid From Cognitively Normal Older Adults

Maureen Handoko, PhD; Marianne Grant, BA; Michael Kuskowski, PhD; Kathleen R. Zahs, PhD; Anders Wallin, MD, PhD; Kaj Blennow, MD, PhD; Karen H. Ashe, MD, PhD
JAMA Neurol. 2013;70(5):594-599. doi:10.1001/jamaneurol.2013.48.
Text Size: A A A
Published online

Importance To improve the ability to develop treatments that prevent incipient Alzheimer disease (AD) from progressing to overt AD, it is important to understand the molecular basis of the earliest pathophysiological abnormalities and to determine how amyloid-β (Aβ) is involved very early in its pathogenesis.

Objective To investigate 2 specific Aβ oligomers, Aβ trimers and Aβ*56, in human cerebrospinal fluid (CSF); evaluate the effects of aging and AD; and obtain support for the hypothesis that they may be pathogenic by determining their relationships to CSF tau.

Design A CSF sampling study.

Settings The University of Minnesota Medical School in Minneapolis, Minnesota, and the Salhgrenska University Hospital, Sweden.

Participants Forty-eight older adults with mild cognitive impairment or AD (impaired group); 49 age-matched cognitively intact control subjects (unimpaired group); and 10 younger, normal control subjects.

Main Outcome Measures Measurements of CSF Aβ trimers, Aβ*56, the 42–amino acid Aβ isoform (Aβ1-42), total tau (T-tau), and phospho-tau 181 (p-tau181). The hypothesis being tested was formulated after data collection.

Results We observed that Aβ trimers and Aβ*56 levels increased with age; within the unimpaired group, they were elevated in subjects with T-tau/Aβ1-42 ratios greater than a cutoff that distinguished the unimpaired group from subjects with AD. In the unimpaired group, T-tau and p-tau181 were found to correlate strongly with Aβ trimers and Aβ*56 (>   0.63), but not with Aβ1-42 (−0.10 < r < −0.01). The strong correlations were found to be attenuated in the impaired group.

Conclusions and Relevance In cognitively intact older adults, CSF Aβ trimers and Aβ*56 were elevated in individuals at risk for AD, and they showed stronger relationships with tau than did Aβ1-42, a surrogate for Aβ fibril deposition. These findings suggest that prior to overt symptoms, 1 or both of the Aβ oligomers, but not fibrillar Aβ, is coupled to tau; however, this coupling is weakened or broken when AD advances to symptomatic stages. The uncoupling is interesting in light of the failure of experimental Aβ therapies to improve mild cognitive impairment/AD, which has prompted a shift in the timing of Aβ therapies to asymptomatic subjects. Knowing which Aβ species to target in asymptomatic subjects may enhance the success of future treatments for AD.

Figures in this Article

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

Figures

Place holder to copy figure label and caption
Graphic Jump Location

Figure 1. Alzheimer disease–related, age-dependent increase in cerebrospinal fluid amyloid-β (Aβ) oligomers, Aβ*56 and Aβ trimers. In cognitively normal subjects, cerebrospinal fluid Aβ*56 and Aβ trimers increased with aging (A and B), and they were higher in subjects with total tau (T-tau)/Aβ1-42 ratios greater than 1.005 (C), which provided sensitivity of 92.3% and specificity of 89.6% for distinguishing cognitively normal older adults from subjects with Alzheimer disease. DLU indicates densitometry light units. The asterisks indicate P < .05.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 2. Strong relationships between cerebrospinal fluid amyloid-β (Aβ) trimers, Aβ*56, and tau in cognitively normal older adults. In cognitively normal older adults, strong relationships were observed between cerebrospinal fluid Aβ*56, Aβ trimers, and total tau (T-tau) (A and B) and phospho-tau 181 (p-tau181) (D and E), but not between Aβ1-42 and T-tau (C) or p-tau181 (F). DLU indicates densitometry light units.

Place holder to copy figure label and caption
Graphic Jump Location

Figure 3. Attenuated relationships between cerebrospinal fluid amyloid-β (Aβ) trimers, Aβ*56, and tau in impaired adults. In subjects with mild cognitive impairment or Alzheimer disease, relationships between the cerebrospinal fluid Aβ*56, Aβ trimers, and total tau (T-tau) (A and B) or phospho-tau 181 (p-tau181) (D and E) were attenuated relative to age-matched control subjects (Figure 2A, B, D, and E), but they were stronger between Aβ1-42 and tau (C and F). DLU indicates densitometry light units.

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 3

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
Jobs
brightcove.createExperiences();